ArticleRadiology case reports2025
Pediatric eosinophilic granulomatosis with polyangiitis presenting as a mediastinal mass in a 6-year-old boy.
Article in Radiology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eosinophilic granulomatosis with polyangiitis (EGPA) is a small vessel vasculitis characterized by asthma, eosinophilia, and small vessel necrotizing granulomatosis with annual incidence of 0.5-4.2 cases per million. EGPA is uncommon in childhood and only a handful of pediatric cases have been reported in the literature making it difficult to diagnose. EGPA in the pediatric population presenting with mediastinal mass is extremely rare. Here, we present a rare case of pediatric EGPA with unique presentation i.e. mediastinal lymphadenopathy in a 6-year-old boy who presented with recurrent episodes of cough and shortness of breath. On further evaluation, patient was found to have mediastinal lymphadenopathy and the diagnosis of pediatric EGPA was confirmed by histopathology of the mass. High dose steroid was started at 1mg/kg/day and then gradually tapered to maintenance dose and weaned off after remission. Diagnosis of EGPA in pediatric population is challenging and requires careful differentiation under mimicking conditions. Though uncommon, EGPA can cause mediastinal lymphadenopathy and should be considered a differential diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.